Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 10257
Gene Symbol: ABCC4
ABCC4
0.300 Biomarker group CTD_human Genome wide association for addiction: replicated results and comparisons of two analytic approaches. 20098672 2010
Entrez Id: 3983
Gene Symbol: ABLIM1
ABLIM1
0.300 Biomarker group CTD_human Genome wide association for addiction: replicated results and comparisons of two analytic approaches. 20098672 2010
Entrez Id: 57007
Gene Symbol: ACKR3
ACKR3
0.010 Biomarker group BEFREE G protein-coupled receptor heteromers are key players in substance use disorder. 30278192 2019
Entrez Id: 105
Gene Symbol: ADARB2
ADARB2
0.300 Biomarker group CTD_human Genome wide association for addiction: replicated results and comparisons of two analytic approaches. 20098672 2010
Entrez Id: 23284
Gene Symbol: ADGRL3
ADGRL3
0.010 Biomarker group BEFREE The genetic models used remained highly efficient in predicting SUD in a large sample of individuals with severe SUD from a psychiatric institution that were not ascertained on the basis of ADHD diagnosis, thus identifying ADGRL3 as a risk gene for SUD. 30696812 2019
Entrez Id: 148
Gene Symbol: ADRA1A
ADRA1A
0.010 Biomarker group BEFREE G protein-coupled receptor heteromers are key players in substance use disorder. 30278192 2019
Entrez Id: 151
Gene Symbol: ADRA2B
ADRA2B
0.010 Biomarker group BEFREE G protein-coupled receptor heteromers are key players in substance use disorder. 30278192 2019
Entrez Id: 3899
Gene Symbol: AFF3
AFF3
0.300 Biomarker group CTD_human Genome wide association for addiction: replicated results and comparisons of two analytic approaches. 20098672 2010
Entrez Id: 84871
Gene Symbol: AGBL4
AGBL4
0.300 Biomarker group CTD_human Genome wide association for addiction: replicated results and comparisons of two analytic approaches. 20098672 2010
Entrez Id: 181
Gene Symbol: AGRP
AGRP
0.010 GeneticVariation group BEFREE Chronic pain and SUD had a negative impact on ART adherence. 31658202 2019
Entrez Id: 9465
Gene Symbol: AKAP7
AKAP7
0.300 Biomarker group CTD_human Genome wide association for addiction: replicated results and comparisons of two analytic approaches. 20098672 2010
Entrez Id: 213
Gene Symbol: ALB
ALB
0.010 Biomarker group BEFREE The globulins were higher in the HCV+ group and the albumin was lower and fell more markedly with age than in N-SUD or HCV- (all P < 0.001). 18811680 2009
Entrez Id: 216
Gene Symbol: ALDH1A1
ALDH1A1
0.010 Biomarker group BEFREE Results from this study suggest that ALDH1A1*2 may be associated with protection from the development of alcohol and other substance use disorders. 15597079 2004
Entrez Id: 55821
Gene Symbol: ALLC
ALLC
0.010 GeneticVariation group BEFREE We examined the association of CTF score with risk for psychiatric and substance use disorders in these samples and the OZ-ALC GWAS sample (N = 1538) in which CT Study factor loadings were applied. 26811803 2016
Entrez Id: 121601
Gene Symbol: ANO4
ANO4
0.300 Biomarker group CTD_human Genome wide association for addiction: replicated results and comparisons of two analytic approaches. 20098672 2010
Entrez Id: 55198
Gene Symbol: APPL2
APPL2
0.300 Biomarker group CTD_human Genome wide association for addiction: replicated results and comparisons of two analytic approaches. 20098672 2010
Entrez Id: 23237
Gene Symbol: ARC
ARC
0.010 GeneticVariation group BEFREE Repeated measurements of anxiety sensitivity and coping motives throughout treatment were examined from a randomized clinical trial comparing usual, CBT-based treatment at a substance use disorder specialty clinic (UC) to that usual care plus a brief CBT for anxiety program for patients with comorbid anxiety and substance use disorders (CALM ARC). 29852309 2018
Entrez Id: 9048
Gene Symbol: ARTN
ARTN
0.010 GeneticVariation group BEFREE Chronic pain and SUD had a negative impact on ART adherence. 31658202 2019
Entrez Id: 481
Gene Symbol: ATP1B1
ATP1B1
0.300 Biomarker group CTD_human Genome wide association for addiction: replicated results and comparisons of two analytic approaches. 20098672 2010
Entrez Id: 9914
Gene Symbol: ATP2C2
ATP2C2
0.010 Biomarker group BEFREE The significant association between age of initiation and ATP2C2 is consistent with the role of calcium signalling mechanisms in substance use disorders. 30003630 2018
Entrez Id: 552
Gene Symbol: AVPR1A
AVPR1A
0.010 Biomarker group BEFREE The AVPR1A gene and substance use disorders: association, replication, and functional evidence. 21514569 2011
Entrez Id: 9531
Gene Symbol: BAG3
BAG3
0.010 Biomarker group BEFREE One-hundred thirty-three obese individuals presenting for bariatric surgery (77.4% female) completed the BIS-15 and the Yale Food Addiction Scale (YFAS) 2.0, which measures addiction-like eating based on the eleven symptoms of substance use disorder outlined in the fifth version of the Diagnostic and Statistical Manual of Mental Disorders. 27768944 2017
Entrez Id: 8213
Gene Symbol: BAS
BAS
0.010 Biomarker group BEFREE BIS and BAS subscale total scores, inter-domain correlation, factor structure, and difference in the early-onset and late-onset SUD subgroup scores were calculated. 30405263 2019
Entrez Id: 8412
Gene Symbol: BCAR3
BCAR3
0.300 Biomarker group CTD_human Genome wide association for addiction: replicated results and comparisons of two analytic approaches. 20098672 2010
Entrez Id: 627
Gene Symbol: BDNF
BDNF
0.030 AlteredExpression group BEFREE We conducted a systematic search of electronic databases to identify studies comparing peripheral plasma or serum BDNF levels in adults with SUDs vs. non-user controls. 30347311 2018